Craniotomy
Conditions
Brief summary
This is a post market prospective, multi-center study of up to 75 participants at approximately 8 clinical study sites. The objective of the study is to evaluate safety by assessing incidence of device and/or procedure related adverse events.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Males and females of any age undergoing craniotomy * Able to return for scheduled study visits * Informed consent is able to be obtained
Exclusion criteria
* Life expectancy \< 12 months * Local cerebral infection * Previous surgery at same anatomical site * Currently enrolled in another study that would affect validity of study * Known hypersensitivity to bovine collagen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Device and/or Procedure Related Adverse Events | 12 months |
Secondary
| Measure | Time frame |
|---|---|
| Rate of cerebrospinal fluid leakage | 12 months |
| Incidence of re-operation | 12 months |
Countries
Austria, Spain